Generation of magnetic nonviral gene transfer agents and magnetofection in vitro

Nature Protocols

Volumn 2, Issue 10, 2007, Pages 2391-2411

  Mykhaylyk, Olga ^a   Antequera, Yolanda Sánchez ^a   Vlaskou, Dialekti ^a   Plank, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; IRON; NANOPARTICLE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CHEMISTRY; CULTURE TECHNIQUE; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; METHODOLOGY; REPORTER GENE;

CELL CULTURE TECHNIQUES; CELLS, CULTURED; DNA; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IRON; NANOPARTICLES; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION;

EID: 38449098069     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.352     Document Type: Article

References (46)

1. Plank, C., Scherer, F. & Rudolph, C.: DNA Pharmaceuticals (ed. Schleef, M.) 55-116 (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2005).
2. Felgner, P.L. et al. Nomenclature for synthetic gene delivery systems. Hum. Gene Ther. 8, 511-512 (1997).
3. Plank, C., Anton, M., Rudolph, C., Rosenecker, J. & Krotz, F. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin. Biol. Ther. 3, 745-758 (2003).
4. Hughes, C., Galea-Lauri, J., Farzaneh, F. & Darling, D. Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Mot. Ther 3, 623-630 (2001).
5. Mah, C. et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mot. Ther 6, 106-112 (2002).
6. Pandori, M.W., Hobson, D.A. & Sano, T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy to localized gene delivery. Virology 299, 204-212 (2002).
7. Hirao, K. et al. Targeted gene delivery to human osteosarcoma cellswith magnetic cationic liposomes under a magnetic field. Int. J. Oncol. 22, 1065-1071 (2003).
8. Satoh, K. et al. Virus concentration using polyethyleneimine-conjugated magnetic beads for improving the sensitivity of nucleic acid amplification tests. J. Virol. Methods 114, 11-19 (2003).
9. Xiang, J.J. et al. IONP-PLL: a novel non-viral vector for efficient gene delivery. J. Gene Med. 5, 803-817 (2003).
10. Campos, S.K., Parrott, M.B. & Barry, M.A. Avidin-based targeting and purification ofa protein IX-modified, metabolically biotinylated adenoviral vector. Mot. Ther 9, 942-954 (2004).
11. Raty, J.K. et al. Enhanced gene delivery by avidin-displaying baculovirus. Mot. Ther. 9, 282-291 (2004).
12. Chan, L. et al. Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. J. Virot. 79, 13190-13194 (2005).
13. Haim, H., Steiner, I. & Panet, A. Synchronized infection of cell cultures by magnetically controlled virus. J. Virol. 79, 622-625 (2005).
14. Kadota, S., Kanayama, T., Miyajima, N., Takeuchi, K. & Nagata, K. Enhancing of measles virus infection by magnetofection. J. Virol. Methods 128, 61-66 (2005).
15. Morishita, N. et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem. Biophys. Res. Commun. 334, 1121-1126 (2005).
16. Isalan, M., Santori, M.I., Gonzalez, C. & Serrano, L. Localized transfection on arrays of magnetic beads coated with PCR products. Nat. Methods 2, 113-118
17. Hafeli, U.O. Magnetically modulated therapeutic systems. Int J. Pharm. 277, 19-24 (2004).
18. Widder, K.J., Senyel, A.E. & Scarpelli, G.D. Magnetic microspheres: a modelsystem of site specific drug delivery in vivo. Proc. Soc. Exp. Biol. Med. 158, 141-146 (1978).
19. Mah, C. et al. Microsphere-mediated delivery of recombinant AAV vectors in vitro and in vivo. Mol. Ther. 1, S239 (2000).
20. Plank, C., Scherer, F., Schillinger, U. & Anton, M. Magnetofection: enhancement and localization ofgene delivery with magnetic particles underthe influence ofa magnetic field. J. Gene. Med. 2, 24 (2000).
21. Scherer, F. et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene. Ther. 9, 102-109 (2002).
22. Nesbeth, D. et al. Metabolic biotinylation of lentiviral pseudotypes for scalable paramagnetic microparticle-dependent manipulation. Mol. Ther. 13, 814-822
23. Huth, S. et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6, 923-936 (2004).
24. Weissleder, R. et al. Superparamagneticironoxide: pharmacokineticsandtoxicity. AJRAm. J. Roentgenol. 152, 167-173 (1989).
25. Schillinger, U. et al. Advances in magnetofection—magnetically guided nucleic acid delivery. J. Magnetism Magnetic Mater. 293, 501-508 (2005).
26. Plank, C. et al. The magnetofection method: using magnetic force to enhance gene delivery. Biol. Chem. 384, 737-747 (2003).
27. Dobson, J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 13, 283-287 (2006).
28. Smith, C. Sharpening the tools of RNA interference. Nat. Methods 3, 475-486 (2006).
29. Krotz, F. et al. Magnetofection—a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol. Ther. 7, 700-710 (2003).
30. Boussif, O. et al. A versatile vectorforgene and oligonucleotide transferinto cells incultureand in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297-7301 (1995).
31. Riess, JG. Fluorous micro-and nanophases with a biomedical perspective. Tetrahedron Fluorous Chem. 58, 4113-4131 (2002).
32. Mykhaylyk, O. et al. Magnetic nanoparticle formulations for DNA and siRNA delivery. J. Magnetism Magnetic Mater. 311, 275-281 (2007).
33. Mikhaylova, M. et al. Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir 20, 2472-2477 (2004).
34. Prozorov, R., Yeshurun, Y., Prozorov, T. & Gedanken, A. Magnetic irreversibility and relaxation in assembly of ferromagnetic nanoparticles. Phys. Rev. B 59, 6956LP-6965 (1999).
35. Kowalski, J.B. & Tallentire, A. Substantiation of 25 kGy as a sterilization dose: a rational approach to establishing verification dose. Radiat. Phys. Chem. 54, 55-64 (1999).
36. Azzam, T. & Domb, A.J. Current developments in gene transfection agents. Curr. Drug Deliv. 1, 165-193 (2004).
37. Bonetta, L. The inside scoop—evaluating gene delivery methods. Nat. Methods 2, 875-883 (2005).
38. Moghimi, S.M. et al. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 11, 990-995 (2005).
39. Wightman, L. et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3, 362-372 (2001).
40. Lungwitz, U., Breunig, M., Blunk, T. & Gopferich, A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60, 247-266 (2005).
41. Boeckle, S. et al. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 6, 1102-1111 (2004).
42. Mueller, H., Kassack, M.U. & Wiese, M.: Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J. Biomol. Screen. 9, 506-515 (2004).
43. Berridge, M.V., Herst, P.M. & Tan, A.S. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11, 127-152 (2005).
44. Berridge, M.V., Tan, A.S. & Hilton, C.J.: Cyclic adenosine monophosphate promotes cell survival and retards apoptosis in a factor-dependent bone marrow-derived cell line. Exp. Hematol. 21, 269-276 (1993).
45. Terebesi, J., Kwok, K.Y. & Rice, K.G. Iodinated plasmid DNA as a tool for studying gene delivery. Anal. Biochem. 263, 120-123 (1998).
46. Krieg, A.M.: CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760 (2002).